Oxford Asset Management’s Genocea Biosciences, Inc. GNCA Stock Holding History

Oxford Asset Management’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-13,035	Closed	-$27K	–	1726
2019 Q4	$27K	Buy	+13,035	New	+$30.9K	﹤0.01%	1693
2018 Q3	–	Sell	-9,061	Closed	-$63K	–	2076
2018 Q2	$63K	Buy	+9,061	New	+$67.8K	﹤0.01%	1651
2017 Q3	–	Sell	-4,884	Closed	-$204K	–	1810
2017 Q2	$204K	Buy	+4,884	New	+$235K	﹤0.01%	1355
2016 Q2	–	Sell	-7,528	Closed	-$466K	–	929
2016 Q1	$466K	Buy	+7,528	New	+$239K	0.01%	621

Other funds holding GNCA

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Oxford Asset Management's GNCA Position: Q1 2020 in Review

Oxford Asset Management sold out of Genocea Biosciences, Inc. (GNCA) in Q1 2020, closing a stake of 13,035 shares — an estimated $27K sold.

Oxford Asset Management first reported a position in GNCA in Q1 2016 and held it in 4 quarters. The position peaked at $466K in Q1 2016. 33 funds tracked by Wall St. Rank hold GNCA as of Q1 2020.

Oxford Asset Management reported no remaining Genocea Biosciences, Inc. position as of Q1 2020 after selling out during the quarter.
Oxford Asset Management sold 13,035 Genocea Biosciences, Inc. shares in Q1 2020, an estimated $27K.
Oxford Asset Management first reported a position in Genocea Biosciences, Inc. in Q1 2016 and held it in 4 quarters.
Oxford Asset Management's Genocea Biosciences, Inc. position peaked at $466K in Q1 2016.
33 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.